Literature DB >> 28498428

Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.

Yanqiu Zhang1, Jing Sui1, Xian Shen1, Chengyun Li1, Wenzhuo Yao1, Weiwei Hong1, Hui Peng1, Yuepu Pu1, Lihong Yin1, Geyu Liang1.   

Abstract

Lung cancer is one of the most lethal malignancies worldwide. To reduce the high morbidity and mortality of the disease, sensitive and specific biomarkers for early detection are urgently needed. Tumor-specific microRNAs (miRNAs) seem to be potential biomarkers for the early diagnosis and treatment of cancer. In this study, the microarray of miRNAs and mRNAs on the same samples was performed and the intersection taken with The Cancer Genome Atlas (TCGA) lung cancer miRNA/RNAseq dataset. Then, miRNA-mRNA regulatory network was constructed to identify miRNA candidates associated with lung cancer through integrating gene expression and miRNA-target prediction. Furthermore, the expression levels of miRNA candidates were validated by stem-loop real-time reverse transcription PCR (qRT-PCR) in larger lung cancer population. The relationship between signature miRNAs and the risk of lung cancer were assessed by conditional logistic regression analysis. Diagnostic value of these miRNAs was determined by areas under receiver operating characteristic curves (ROC). The Affymetrix microarray analysis identified a total of 116 miRNAs and 502 mRNAs that could distinguish lung tumor tissues from adjacent non-tumor tissues, of which 70 miRNAs and 136 mRNAs were upregulated, while 46 miRNAs and 366 mRNAs were downregulated, respectively. In combination with TCGA analysis, we identified 32 miRNAs and 377 mRNAs related to lung cancer. Then, 28 key miRNAs related to 61 inter-section mRNAs were identified by miRNA-mRNA network analysis. The miRNA function analysis was indicative of that 18 upregulated and 10 downregulated miRNAs involved in signaling pathways related to Environmental Information Processing and Human Diseases. Population result showed that the expression of 7 miRNAs (miR-205-5p, miR-3917, miR-30a-3p, miR-30a-5p, miR-30c-2-3p, miR-30d-5p and miR-27a-5p) was consistent with the analysis result of microarray and TCGA. In addition, upregulation of miR-205-5p, miR-3917 and downregulation of miR-30a-3p, miR-30a-5p, miR-30c-2-3p, miR-30d-5p, miR-27a-5p increased the risk of lung cancer by conditional logistic regression analysis. The diagnostic accuracy of miR-205-5p, miR-3917, miR-27a-5p, miR-30a-3p, miR-30a-5p, miR-30c-2-3p, miR-30d-5p showed that their corresponding AUCs were 0.728, 0.661, 0.637, 0.758, 0.772, 0.734, 0.776, respectively. Therefore, there are a set of signature miRNAs which may be promising biomarkers for the early screening of high-risk populations and early diagnosis of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28498428     DOI: 10.3892/or.2017.5612

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  26 in total

1.  MicroRNA expression profiling provides novel insights into immune-related pathways involved in gastric cancer.

Authors:  Mário Rino Martins; Renata Santos Almeida; Norma Lucena-Silva; Cláudia Malheiros Coutinho-Camilo; Israel Torjal; Rogério Luiz Dos Santos; Cristiana Libardi Miranda-Furtado; Álvaro Fabrício Lopes Rios; Leuridan Cavalcante Torres; Maria Dirlei F S Begnami
Journal:  Med Oncol       Date:  2019-08-09       Impact factor: 3.064

2.  The diagnostic value of miR-145 and miR-205 in patients with cervical cancer.

Authors:  Furong Yu; Jie Liu; Weilei Dong; Jing Xie; Xia Zhao
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

3.  MicroRNA-21 promotes the proliferation, migration and invasion of non-small cell lung cancer A549 cells by regulating autophagy activity via AMPK/ULK1 signaling pathway.

Authors:  Shuping Li; Xiaofei Zeng; Ruidong Ma; Li Wang
Journal:  Exp Ther Med       Date:  2018-06-29       Impact factor: 2.447

4.  MiR-19b-3p promotes tumor progression of non-small cell lung cancer via downregulating HOXA9 and predicts poor prognosis in patients.

Authors:  Zu-Lei Li; Dong Li; Guo-Qiang Yin
Journal:  Histol Histopathol       Date:  2022-03-11       Impact factor: 2.130

5.  Serum microRNA-592 serves as a novel potential biomarker for early diagnosis of colorectal cancer.

Authors:  Zhenguo Pan; Lin Miao
Journal:  Oncol Lett       Date:  2020-05-28       Impact factor: 2.967

6.  MicroRNAs as biomarkers for the progression and prognosis of colon carcinoma.

Authors:  Hui Zhang; Zhuo Wang; Rong Ma; Jianzhong Wu; Jifeng Feng
Journal:  Int J Mol Med       Date:  2018-07-25       Impact factor: 4.101

7.  Diagnosis value of aberrantly expressed microRNA profiles in lung squamous cell carcinoma: a study based on the Cancer Genome Atlas.

Authors:  Sheng Yang; Jing Sui; Geyu Liang
Journal:  PeerJ       Date:  2017-11-30       Impact factor: 2.984

8.  miR‑378a‑3p exerts tumor suppressive function on the tumorigenesis of esophageal squamous cell carcinoma by targeting Rab10.

Authors:  Naixin Ding; Xiujin Sun; Tingting Wang; Lei Huang; Jing Wen; Yiqin Zhou
Journal:  Int J Mol Med       Date:  2018-04-24       Impact factor: 4.101

9.  Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma.

Authors:  Xiwen Liao; Guangzhi Zhu; Rui Huang; Chengkun Yang; Xiangkun Wang; Ketuan Huang; Tingdong Yu; Chuangye Han; Hao Su; Tao Peng
Journal:  Cancer Manag Res       Date:  2018-04-13       Impact factor: 3.989

10.  β-elemene suppresses Warburg effect in NCI-H1650 non-small-cell lung cancer cells by regulating the miR-301a-3p/AMPKα axis.

Authors:  Lin Li; Dongkai Zhao; Guangyu Cheng; Qingjie Li; Yunjie Chu; Hongbo Chu; Yunlu Ding; Chikun Li
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.